[1] |
中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版)[J]. 中华神经科杂志, 2022, 55(9): 931-949.
|
[2] |
Jiang Y, Dai S, Jia L, et al. Single-cell transcriptomics reveals cell type-specific immune regulation associated with anti-NMDA receptor encephalitis in humans[J]. Front Immunol, 2022, 13: 1075675.
|
[3] |
Sun B, Ramberger M, O'Connor KC, et al. The B cell immunobiology that underlies CNS autoantibody-mediated diseases[J]. Nat Rev Neurol, 2020, 16(9): 481-492.
doi: 10.1038/s41582-020-0381-z
pmid: 32724223
|
[4] |
Wang Y, Zhang W, Yin J, et al. Anti-N-methyl-D-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes[J]. J Neuroimmunol, 2017, 312: 59-65.
doi: S0165-5728(17)30003-6
pmid: 28935354
|
[5] |
Li X, Hou C, Wu WL, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis in southern China: Analysis of 111 cases[J]. J Neuroimmunol, 2021, 352: 577479.
|
[6] |
Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis[J]. Lancet Neurol, 2011, 10(1): 63-74.
doi: 10.1016/S1474-4422(10)70253-2
pmid: 21163445
|
[7] |
Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15(4): 391-404.
doi: 10.1016/S1474-4422(15)00401-9
pmid: 26906964
|
[8] |
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. Lancet Neurol, 2013, 12(2): 157-165.
doi: 10.1016/S1474-4422(12)70310-1
pmid: 23290630
|
[9] |
Wang W, Li JM, Hu FY, et al. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China[J]. Eur J Neurol, 2016, 23(3): 621-629.
doi: 10.1111/ene.12911
pmid: 26563553
|
[10] |
Huang Q, Wu Y, Qin R, et al. Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis[J]. J Neurol, 2016, 263(12): 2446-2455.
pmid: 27632180
|
[11] |
Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis[J]. Lancet Neurol, 2018, 17(9): 760-772.
doi: S1474-4422(18)30244-8
pmid: 30049614
|
[12] |
Favier M, Joubert B, Picard G, et al. Initial clinical presentation of young children with N-methyl-D-aspartate receptor encephalitis[J]. Eur J Paediatr Neurol, 2018, 22(3): 404-411.
|
[13] |
Ho AC, Chan SH, Chan E, et al. Anti-N-methyl-D-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong[J]. Brain Dev, 2018, 40(6): 473-479.
|
[14] |
Lee SH, Atiya N, Wang SM, et al. Loss of transfected human brain micro-vascular endothelial cell integrity during herpes simplex virus infection[J]. Intervirology, 2018, 61(4): 193-203.
doi: 10.1159/000495180
pmid: 30541013
|
[15] |
Dalmau J. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture[J]. Neurology, 2016, 87(23): 2471-2482.
pmid: 27920282
|
[16] |
Stahl JP, Mailles A. Herpes simplex virus encephalitis update[J]. Curr Opin Infect Dis, 2019, 32(3): 239-243.
doi: 10.1097/QCO.0000000000000554
pmid: 30921087
|
[17] |
Wang H. A protocol for investigating the association of vaccination and anti-NMDA receptor encephalitis[J]. Front Biosci (Schol Ed), 2018, 10(2): 229-237.
doi: 10.2741/s511
pmid: 28930529
|